Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pancreatic cancer.

Anirban Maitra1, Ralph H Hruban

  • 1Department of Pathology, The Sol Goldman Pancreatic Cancer Research Center, Johns Hopkins University School of Medicine, Baltimore, MD 21231, USA. amaitra1@jhmi.edu

Annual Review of Pathology
|November 28, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Epithelial memory of inflammation limits tissue damage while promoting pancreatic tumorigenesis.

Science (New York, N.Y.)·2021
Same author

GRP78 expression and prognostic significance in patients with pancreatic ductal adenocarcinoma treated with neoadjuvant therapy versus surgery first.

Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]·2021
Same author

Elucidation of Tumor-Stromal Heterogeneity and the Ligand-Receptor Interactome by Single-Cell Transcriptomics in Real-world Pancreatic Cancer Biopsies.

Clinical cancer research : an official journal of the American Association for Cancer Research·2021
Same author

Early detection of pancreatic cancer: current state and future opportunities.

Current opinion in gastroenterology·2021
Same author

PRMT1-dependent regulation of RNA metabolism and DNA damage response sustains pancreatic ductal adenocarcinoma.

Nature communications·2021
Same author

Longitudinal assessment of lung clearance index to monitor disease progression in children and adults with cystic fibrosis.

Thorax·2021
Same journal

Basic Microglial Functions and How They Go Awry in Neurodegenerative Disease.

Annual review of pathology·2026
Same journal

Integration and Intersection of Cancer Metabolism with Epigenetic Pathways in Gliomas.

Annual review of pathology·2025
Same journal

The Role of Fibroblasts Across Inflammation and Immunity.

Annual review of pathology·2025
Same journal

The Role of MicroRNAs in Viral and Bacterial Infections.

Annual review of pathology·2025
Same journal

Role of Immune Cells in Hepatitis B Virus and Associated Sequelae.

Annual review of pathology·2025
Same journal

Pathology of the Coronary Arteries and Myocardium in Kawasaki Disease.

Annual review of pathology·2025
See all related articles

Pancreatic cancer arises from inherited and somatic gene mutations, including KRAS2 and TP53. Research identifies precursor lesions and stem-like cells driving tumor growth and treatment resistance.

Area of Science:

  • Oncology
  • Genetics
  • Molecular Biology

Background:

  • Pancreatic cancer is characterized by numerous inherited and somatic gene mutations.
  • Key mutated genes include KRAS2, p16/CDKN2A, TP53, and SMAD4/DPC4.
  • Genomic and transcriptomic alterations drive cancer progression, including cell cycle deregulation, survival, invasion, and metastasis.

Purpose of the Study:

  • To summarize the current understanding of pancreatic cancer genetics and progression.
  • To highlight the identification of precursor lesions and experimental models.
  • To discuss the role of stem-like cells in pancreatic cancer initiation and therapy resistance.

Main Methods:

  • Review of recent research on pancreatic cancer genomics and transcriptomics.
  • Identification and characterization of precursor lesions.

Related Experiment Videos

  • Development and utilization of genetically engineered mouse models.
  • Investigation of stem-like cell populations in pancreatic cancer.

    • Main Results:

    • Pancreatic cancer is fundamentally a disease of gene mutations.
    • Three distinct precursor lesions precede invasive cancer.
    • Genetically engineered mouse models effectively recapitulate human pancreatic cancer progression.
    • Stem-like cells are implicated in tumor initiation, metastasis, and therapeutic resistance.

    Conclusions:

    • Significant advancements have been made in understanding pancreatic cancer biology over the past two decades.
    • The identification of precursor lesions and the development of experimental models are crucial for research.
    • Stem-like cells represent a critical target for future pancreatic cancer therapies.